₹159 Dividend: Aptus, BPCL, HUL, Sanofi and 14 Others Trading Record Date Today, November 07, 2025

Aptus, BPCL, HUL, Sanofi and others go ex-date today with dividends worth ₹159. Sanofi leads with ₹75; Deep Diamond pays the lowest at ₹0.10. Investors must hold shares in their demat account before the ex-date to be eligible for these benefits.

Right Issue

Annvrridhhi Ventures – Right Issue

The company is offering a rights issue of equity shares at a preset, usually discounted price. Only shareholders recorded before the ex-date can apply.

Companies Trading Record Date Today

Aptus Value Housing Finance

Interim dividend: ₹2 per share

Balkrishna Industries

Interim dividend: ₹4 per share

BPCL

Interim dividend: ₹7.50 per share

CAMS (Computer Age Management Services)

Interim dividend: ₹14 per share

Dabur India

Interim dividend: ₹2.75 per share

Deep Diamond India

Interim dividend: ₹0.10 per share

Dr Agarwals Eye Hospital

Interim dividend: ₹3 per share

Godrej Consumer Products (GCPL)

Interim dividend: ₹5 per share

Hindustan Unilever (HUL)

Interim dividend: ₹19 per share

Dr Lal PathLabs

Interim dividend: ₹7 per share

Manappuram Finance

Interim dividend: ₹0.50 per share

Navin Fluorine International

Interim dividend: ₹6.50 per share

NTPC

Interim dividend: ₹2.75 per share

OCCL (Oriental Carbon & Chemicals Ltd)

Interim dividend: ₹1 per share

R R Kabel

Interim dividend: ₹4 per share

Sanofi India

Interim dividend: ₹75 per share (highest)

Shriram Finance

Interim dividend: ₹4.80 per share

Also Read, Dividends and Bonus Issue This Week (November 3-7, 2025)!

Highest and Lowest Dividend Payouts

• Highest: Sanofi India – ₹75 per share
• Lowest: Deep Diamond India – ₹0.10 per share

Conclusion

With ₹159 worth of dividends and multiple corporate actions taking effect today, investors have a range of opportunities to secure payouts. Holding shares before today ensures eligibility for dividends and rights issues, making this an important trading day for market participants.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.